Nuvectis Pharma Inc. Gains 30.19%
Fri, May 06, 2022 at 05:30 PM
Nuvectis Pharma Inc. (NVCT:NASDAQ) soared at $18.2, representing a gain of 30.2%. On Thu, May 05, 2022, NVCT:NASDAQ hit a New 2-Week High of $13.98. The stock got featured on our News Catalysts scanner on Wed, Apr 13, 2022 at 10:02 AM in the 'BIOTECH' category. From Fri, Apr 22, 2022, the stock recorded 33.33% Up Days and 50.00% Green Days
About Nuvectis Pharma Inc. (NVCT:NASDAQ)
Nuvectis Pharma Inc is a biopharmaceutical company.
Top 10 Gainers:
- Sidus Space Inc. (SIDU:NASDAQ), 51.78%
- The Arena Group Holdings Inc. (AREN:NYSEMKT), 43.54%
- Nuvectis Pharma Inc. (NVCT:NASDAQ), 30.19%
- Vinco Ventures Inc. (BBIG:NASDAQ), 28.02%
- Tabula Rasa HealthCare, Inc. (TRHC:NASDAQ), 27.33%
- Funko, Inc. (FNKO:NASDAQ), 26.91%
- Swvl Holdings Corp (SWVL:NASDAQ), 23.88%
- Forge Global Holdings Inc. (FRGE:NYSE), 20.67%
- Global Cord Blood Corporation (CO:NYSE), 19.55%
- DMC Global Inc. (BOOM:NASDAQ), 19.3%